Literature DB >> 21803122

Increased hippocampal quinone reductase 2 in Alzheimer's disease.

Tetsuya Hashimoto1, Masami Nakai.   

Abstract

Quinone reductase 2 (QR2), a detoxifying cytosolic flavoenzyme, is thought to play an important role in the acquisition and loss of memory. We determined the amount of QR2 in the hippocampus, amygdala, and superior frontal gyrus of Alzheimer's disease (AD) patients with dementia by using western blot analysis. The level of QR2 was significantly higher in the hippocampus of AD patients than in that of the control subjects. The relation between QR2 and AD has not yet been determined; however, our results suggest that the increase in hippocampal QR2 might be a cause of AD or might promote the progression of AD by causing an increase in the toxic quinone levels and consequent loss of cognitive function.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21803122     DOI: 10.1016/j.neulet.2011.07.008

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

1.  Crystallization via tubing microfluidics permits both in situ and ex situ X-ray diffraction.

Authors:  Charline J J Gerard; Gilles Ferry; Laurent M Vuillard; Jean A Boutin; Leonard M G Chavas; Tiphaine Huet; Nathalie Ferte; Romain Grossier; Nadine Candoni; Stéphane Veesler
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2017-10-02       Impact factor: 1.056

2.  Dopamine-Dependent QR2 Pathway Activation in CA1 Interneurons Enhances Novel Memory Formation.

Authors:  Nathaniel L Gould; Vijendra Sharma; Mohammad Hleihil; Sailendrakumar Kolatt Chandran; Orit David; Efrat Edry; Kobi Rosenblum
Journal:  J Neurosci       Date:  2020-10-12       Impact factor: 6.167

3.  Sequencing and comparative genomic analysis of 1227 Felis catus cDNA sequences enriched for developmental, clinical and nutritional phenotypes.

Authors:  Kristopher J Irizarry; Sukhaswami B Malladi; Xiangming Gao; Katherine Mitsouras; Lynda Melendez; Patricia A Burris; Jeffrey A Brockman; Samer W Al-Murrani
Journal:  BMC Genomics       Date:  2012-01-18       Impact factor: 3.969

4.  Neuroprotective Properties of Quinone Reductase 2 Inhibitor M-11, a 2-Mercaptobenzimidazole Derivative.

Authors:  Mikhail V Voronin; Ilya A Kadnikov; Liana F Zainullina; Ilya O Logvinov; Ekaterina R Verbovaya; Tatyana A Antipova; Yulia V Vakhitova; Sergei B Seredenin
Journal:  Int J Mol Sci       Date:  2021-12-02       Impact factor: 5.923

5.  Resveratrol-Based MTDLs to Stimulate Defensive and Regenerative Pathways and Block Early Events in Neurodegenerative Cascades.

Authors:  Clara Herrera-Arozamena; Martín Estrada-Valencia; Patricia López-Caballero; Concepción Pérez; José A Morales-García; Ana Pérez-Castillo; Eric Del Sastre; Cristina Fernández-Mendívil; Pablo Duarte; Patrycja Michalska; José Lombardía; Sergio Senar; Rafael León; Manuela G López; María Isabel Rodríguez-Franco
Journal:  J Med Chem       Date:  2022-03-04       Impact factor: 7.446

6.  Muscarinic-Dependent miR-182 and QR2 Expression Regulation in the Anterior Insula Enables Novel Taste Learning.

Authors:  Nathaniel L Gould; Alina Elkobi; Efrat Edry; Jonathan Daume; Kobi Rosenblum
Journal:  eNeuro       Date:  2020-05-29

Review 7.  Melatonin for Neonatal Encephalopathy: From Bench to Bedside.

Authors:  Raymand Pang; Adnan Advic-Belltheus; Christopher Meehan; Daniel J Fullen; Xavier Golay; Nicola J Robertson
Journal:  Int J Mol Sci       Date:  2021-05-22       Impact factor: 6.208

8.  Expression of Quinone Reductase-2 in the Cortex Is a Muscarinic Acetylcholine Receptor-Dependent Memory Consolidation Constraint.

Authors:  Akiva N Rappaport; Eyal Jacob; Vijendra Sharma; Sharon Inberg; Alina Elkobi; Hadile Ounallah-Saad; Metsada Pasmanik-Chor; Efrat Edry; Kobi Rosenblum
Journal:  J Neurosci       Date:  2015-11-25       Impact factor: 6.167

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.